Warning letter
Tibetan Herbal Balance, Inc.: warning letter of Jan 4, 2016
FDA warning letter 451629 · New England District Office
Key facts
| Reference number | 451629 |
|---|---|
| Company | Tibetan Herbal Balance, Inc. |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Jan 4, 2016 |
| Posted date | Jan 4, 2016 |
| Issuing office | New England District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.127, 111.520, 111.15(i), 111.70(f), 111.210(g), 111.210(h)(3), 111.535(b)(1), 111.535(b)(2), 111.75(e), 201.5 |
| Inspection city | Malden |
| Inspection ZIP | 02148 |
| Inspection start date | Dec 18, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: